Risako Suzuki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.
Journal: Frontiers in immunology
Published: March 10, 2026
Elevated plasma IgG is associated with improved treatment response and survival in advanced non‑small cell lung cancer patients treated with anti‑PD‑1 therapy.
Journal: Scientific reports
Published: February 05, 2026
Association of Intratumoral Macrophage Subsets with Treatment Outcomes in Patients with Stage IV Solid Tumors.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 05, 2026
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study.
Journal: Frontiers in immunology
Published: June 03, 2025
Pembrolizumab-Induced Severe Pneumonitis in a Patient With Lung Adenocarcinoma After Umbilical Cord Blood Transplantation: A Case Report.
Journal: Respirology case reports
Published: May 26, 2025
Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression.
Journal: Frontiers in immunology
Published: November 15, 2024
Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: November 15, 2024
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study.
Journal: Frontiers in oncology
Published: September 23, 2024
Last Updated: 09/26/2026